by
Lauren Dubinsky, Senior Reporter | August 31, 2017
Image-guided therapy
Courtesy of Philips
Royal Philips announced on Monday a partnership with HeartFlow Inc. to promote the use of the HeartFlow FFRct Analysis, with Philips’ advanced catheters, for measuring the inside of a patient’s coronary arteries.
The companies will initially focus their efforts on the U.S. market, but have plans to expand globally in the near future. They are also exploring additional collaborations in the fields of diagnostic imaging and advanced informatics.
Heart disease is a leading cause of death in the U.S. About 610,000 Americans die from it every year, according to the Centers for Disease Control and Prevention.
Ad Statistics
Times Displayed: 173747
Times Visited: 3176 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
In order to address this, hospitals are adopting new technology that improves the diagnosis and care of these patients, and reduces unnecessary invasive procedures, Christopher Barys, business leader of Philips image-guided therapy devices, said in a statement.
The HeartFlow FFRct Analysis is the only commercially available noninvasive technology that assesses the extent and impact of coronary artery disease on blood flow to the heart. Data from coronary CT angiograms are transferred from the hospital’s system to the cloud, and HeartFlow uses deep learning technology to generate a digital 3-D model of the patient’s coronary arteries.
Computer algorithms evaluate millions of complex equations to simulate blood flow in the model and determine the impact of blockages. The clinicians can then review the results on a secure web interface.
The advanced catheters that will be promoted in conjunction with HeartFlow FFRct Analysis are Philips’ coronary fractional flow reserve (FFR), instant wave-free ratio (iFR) and intravascular ultrasound (IVUS) solutions.
Siemens Healthineers and GE Healthcare also inked deals with HeartFlow this year. In March,
Siemens brought its CT systems together with HeartFlow FFRct Analysis and
GE paired its CT systems with the technology in July.
In addition to the commercial collaboration agreement between Philips and HeartFlow, the companies have also entered into an exclusive agreement to develop a cath lab X-ray image-derived FFR or iFR solution.
“Our collaboration agreement with Philips, which has an integrated solution within cath labs, will help bring HeartFlow’s technology to more patients with suspected and potentially life-threatening CAD,” said Dr. John H. Stevens, president and CEO of HeartFlow.
Back to HCB News
